Introduction
Brand name: Calfax Suspension
Manufacturer: Astemax Biotech Pvt. Ltd.
Composition per dose / formulation:
Calcium carbonate 625 mg (providing elemental calcium)
Vitamin D3 125 IU (cholecalciferol)
L‑Lysine 50 mg
Calfax Suspension is a calcium‑and‑vitamin‑D‑based liquid formulation designed for bone‑health support and growth‑related needs in children, adolescents, and adults with low‑calcium‑intake diets, osteopenia‑risk, or during growth spurts and convalescence. The suspension form improves palatability and dosing flexibility, especially in paediatric and geriatric patients.
Key benefits
Bone mineralization and growth support: Calcium carbonate provides the main calcium source for bone‑matrix formation and maintenance, while vitamin D3 enhances intestinal calcium absorption and regulates bone turnover.
Amino‑acid synergy: L‑lysine acts as a co‑factor that may improve calcium absorption and collagen formation, supporting musculoskeletal growth and repair.
Typical use and precautions
Usually given as a measured volume (e.g., 5–10 ml twice daily), with dose adjusted as per age, weight, and dietary calcium intake, following local prescribing information.
Astemax markets Calfax Suspension as a FSSAI‑oriented, suspension‑based calcium‑vitamin D3‑L‑lysine formulation suitable for paediatricians, general physicians, and community‑health‑workers managing bone‑health, growth‑deficit, and convalescent‑nutrition scenarios.
